Global Celiac Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Celiac Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine which makes it difficult for the body to absorb nutrients such as iron, fat, calcium, and folate. The immune system mistakes substances inside gluten to be a threat to the body and attacks them, in turn, causing damage to the bowel surface and hampering the body’s ability to absorb nutrition. Digestion problems, dermatitis herpetiformis, abdominal pain, weight loss, musculoskeletal problems, aphthous ulcers, iron deficiency, stunted growth, tingling sensation in the leg, and missed menstrual cycles are some of the symptoms of celiac disease. The disease can lead to various complications and health problems such as miscarriage or infertility, intestinal cancer, osteoporosis, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects. Celiac disease can also lead to various autoimmune diseases such as lupus, thyroid disease, Sjцgren's syndrome, type 1 diabetes, and rheumatoid arthritis. It is difficult to diagnose celiac disease in the initial stages as its symptoms are similar to those of other diseases. Various sensitive and selective blood tests such as anti-tissue transglutaminase antibodies with or without IgA level and IgA anti-endomysial antibodies are used to screen the disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Celiac Drugs industry chain, the market status of Men (First Line Of Treatment, Second Line Of Treatment), Women (First Line Of Treatment, Second Line Of Treatment), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Celiac Drugs.
Regionally, the report analyzes the Celiac Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Celiac Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Celiac Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Celiac Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., First Line Of Treatment, Second Line Of Treatment).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Celiac Drugs market.
Regional Analysis: The report involves examining the Celiac Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Celiac Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Celiac Drugs:
Company Analysis: Report covers individual Celiac Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Celiac Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Men, Women).
Technology Analysis: Report covers specific technologies relevant to Celiac Drugs. It assesses the current state, advancements, and potential future developments in Celiac Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Celiac Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Celiac Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Celiac Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Celiac Drugs, with price, sales, revenue and global market share of Celiac Drugs from 2019 to 2024.
Chapter 3, the Celiac Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Celiac Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Celiac Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Celiac Drugs.
Chapter 14 and 15, to describe Celiac Drugs sales channel, distributors, customers, research findings and conclusion.
Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine which makes it difficult for the body to absorb nutrients such as iron, fat, calcium, and folate. The immune system mistakes substances inside gluten to be a threat to the body and attacks them, in turn, causing damage to the bowel surface and hampering the body’s ability to absorb nutrition. Digestion problems, dermatitis herpetiformis, abdominal pain, weight loss, musculoskeletal problems, aphthous ulcers, iron deficiency, stunted growth, tingling sensation in the leg, and missed menstrual cycles are some of the symptoms of celiac disease. The disease can lead to various complications and health problems such as miscarriage or infertility, intestinal cancer, osteoporosis, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects. Celiac disease can also lead to various autoimmune diseases such as lupus, thyroid disease, Sjцgren's syndrome, type 1 diabetes, and rheumatoid arthritis. It is difficult to diagnose celiac disease in the initial stages as its symptoms are similar to those of other diseases. Various sensitive and selective blood tests such as anti-tissue transglutaminase antibodies with or without IgA level and IgA anti-endomysial antibodies are used to screen the disease.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Celiac Drugs industry chain, the market status of Men (First Line Of Treatment, Second Line Of Treatment), Women (First Line Of Treatment, Second Line Of Treatment), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Celiac Drugs.
Regionally, the report analyzes the Celiac Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Celiac Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Celiac Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Celiac Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., First Line Of Treatment, Second Line Of Treatment).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Celiac Drugs market.
Regional Analysis: The report involves examining the Celiac Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Celiac Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Celiac Drugs:
Company Analysis: Report covers individual Celiac Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Celiac Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Men, Women).
Technology Analysis: Report covers specific technologies relevant to Celiac Drugs. It assesses the current state, advancements, and potential future developments in Celiac Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Celiac Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Celiac Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- First Line Of Treatment
- Second Line Of Treatment
- Men
- Women
- Children
- ADMA Biologics
- Amgen
- Anthera Pharmaceuticals
- Bayer
- Biogen
- BioLineRx
- Biotest
- Bristol-Myers Squibb
- Celgene
- Celimmune
- F Hoffmann-La Roche
- ImmunogenX
- Immunomedics
- ImmusanT
- Innovate Biopharmaceuticals
- Johnson & Johnson
- Kedrion Biopharma
- LFB Group
- Merck
- Novartis
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Celiac Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Celiac Drugs, with price, sales, revenue and global market share of Celiac Drugs from 2019 to 2024.
Chapter 3, the Celiac Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Celiac Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Celiac Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Celiac Drugs.
Chapter 14 and 15, to describe Celiac Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Celiac Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Celiac Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 First Line Of Treatment
1.3.3 Second Line Of Treatment
1.4 Market Analysis by Application
1.4.1 Overview: Global Celiac Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Men
1.4.3 Women
1.4.4 Children
1.5 Global Celiac Drugs Market Size & Forecast
1.5.1 Global Celiac Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Celiac Drugs Sales Quantity (2019-2030)
1.5.3 Global Celiac Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 ADMA Biologics
2.1.1 ADMA Biologics Details
2.1.2 ADMA Biologics Major Business
2.1.3 ADMA Biologics Celiac Drugs Product and Services
2.1.4 ADMA Biologics Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 ADMA Biologics Recent Developments/Updates
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Celiac Drugs Product and Services
2.2.4 Amgen Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Amgen Recent Developments/Updates
2.3 Anthera Pharmaceuticals
2.3.1 Anthera Pharmaceuticals Details
2.3.2 Anthera Pharmaceuticals Major Business
2.3.3 Anthera Pharmaceuticals Celiac Drugs Product and Services
2.3.4 Anthera Pharmaceuticals Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Anthera Pharmaceuticals Recent Developments/Updates
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Celiac Drugs Product and Services
2.4.4 Bayer Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bayer Recent Developments/Updates
2.5 Biogen
2.5.1 Biogen Details
2.5.2 Biogen Major Business
2.5.3 Biogen Celiac Drugs Product and Services
2.5.4 Biogen Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Biogen Recent Developments/Updates
2.6 BioLineRx
2.6.1 BioLineRx Details
2.6.2 BioLineRx Major Business
2.6.3 BioLineRx Celiac Drugs Product and Services
2.6.4 BioLineRx Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 BioLineRx Recent Developments/Updates
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Celiac Drugs Product and Services
2.7.4 Biotest Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biotest Recent Developments/Updates
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb Celiac Drugs Product and Services
2.8.4 Bristol-Myers Squibb Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bristol-Myers Squibb Recent Developments/Updates
2.9 Celgene
2.9.1 Celgene Details
2.9.2 Celgene Major Business
2.9.3 Celgene Celiac Drugs Product and Services
2.9.4 Celgene Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Celgene Recent Developments/Updates
2.10 Celimmune
2.10.1 Celimmune Details
2.10.2 Celimmune Major Business
2.10.3 Celimmune Celiac Drugs Product and Services
2.10.4 Celimmune Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Celimmune Recent Developments/Updates
2.11 F Hoffmann-La Roche
2.11.1 F Hoffmann-La Roche Details
2.11.2 F Hoffmann-La Roche Major Business
2.11.3 F Hoffmann-La Roche Celiac Drugs Product and Services
2.11.4 F Hoffmann-La Roche Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 F Hoffmann-La Roche Recent Developments/Updates
2.12 ImmunogenX
2.12.1 ImmunogenX Details
2.12.2 ImmunogenX Major Business
2.12.3 ImmunogenX Celiac Drugs Product and Services
2.12.4 ImmunogenX Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 ImmunogenX Recent Developments/Updates
2.13 Immunomedics
2.13.1 Immunomedics Details
2.13.2 Immunomedics Major Business
2.13.3 Immunomedics Celiac Drugs Product and Services
2.13.4 Immunomedics Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Immunomedics Recent Developments/Updates
2.14 ImmusanT
2.14.1 ImmusanT Details
2.14.2 ImmusanT Major Business
2.14.3 ImmusanT Celiac Drugs Product and Services
2.14.4 ImmusanT Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 ImmusanT Recent Developments/Updates
2.15 Innovate Biopharmaceuticals
2.15.1 Innovate Biopharmaceuticals Details
2.15.2 Innovate Biopharmaceuticals Major Business
2.15.3 Innovate Biopharmaceuticals Celiac Drugs Product and Services
2.15.4 Innovate Biopharmaceuticals Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Innovate Biopharmaceuticals Recent Developments/Updates
2.16 Johnson & Johnson
2.16.1 Johnson & Johnson Details
2.16.2 Johnson & Johnson Major Business
2.16.3 Johnson & Johnson Celiac Drugs Product and Services
2.16.4 Johnson & Johnson Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Johnson & Johnson Recent Developments/Updates
2.17 Kedrion Biopharma
2.17.1 Kedrion Biopharma Details
2.17.2 Kedrion Biopharma Major Business
2.17.3 Kedrion Biopharma Celiac Drugs Product and Services
2.17.4 Kedrion Biopharma Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Kedrion Biopharma Recent Developments/Updates
2.18 LFB Group
2.18.1 LFB Group Details
2.18.2 LFB Group Major Business
2.18.3 LFB Group Celiac Drugs Product and Services
2.18.4 LFB Group Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 LFB Group Recent Developments/Updates
2.19 Merck
2.19.1 Merck Details
2.19.2 Merck Major Business
2.19.3 Merck Celiac Drugs Product and Services
2.19.4 Merck Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Merck Recent Developments/Updates
2.20 Novartis
2.20.1 Novartis Details
2.20.2 Novartis Major Business
2.20.3 Novartis Celiac Drugs Product and Services
2.20.4 Novartis Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Novartis Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CELIAC DRUGS BY MANUFACTURER
3.1 Global Celiac Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Celiac Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Celiac Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Celiac Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Celiac Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Celiac Drugs Manufacturer Market Share in 2023
3.5 Celiac Drugs Market: Overall Company Footprint Analysis
3.5.1 Celiac Drugs Market: Region Footprint
3.5.2 Celiac Drugs Market: Company Product Type Footprint
3.5.3 Celiac Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Celiac Drugs Market Size by Region
4.1.1 Global Celiac Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Celiac Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Celiac Drugs Average Price by Region (2019-2030)
4.2 North America Celiac Drugs Consumption Value (2019-2030)
4.3 Europe Celiac Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Celiac Drugs Consumption Value (2019-2030)
4.5 South America Celiac Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Celiac Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Celiac Drugs Sales Quantity by Type (2019-2030)
5.2 Global Celiac Drugs Consumption Value by Type (2019-2030)
5.3 Global Celiac Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Celiac Drugs Sales Quantity by Application (2019-2030)
6.2 Global Celiac Drugs Consumption Value by Application (2019-2030)
6.3 Global Celiac Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Celiac Drugs Sales Quantity by Type (2019-2030)
7.2 North America Celiac Drugs Sales Quantity by Application (2019-2030)
7.3 North America Celiac Drugs Market Size by Country
7.3.1 North America Celiac Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Celiac Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Celiac Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Celiac Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Celiac Drugs Market Size by Country
8.3.1 Europe Celiac Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Celiac Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Celiac Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Celiac Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Celiac Drugs Market Size by Region
9.3.1 Asia-Pacific Celiac Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Celiac Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Celiac Drugs Sales Quantity by Type (2019-2030)
10.2 South America Celiac Drugs Sales Quantity by Application (2019-2030)
10.3 South America Celiac Drugs Market Size by Country
10.3.1 South America Celiac Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Celiac Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Celiac Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Celiac Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Celiac Drugs Market Size by Country
11.3.1 Middle East & Africa Celiac Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Celiac Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Celiac Drugs Market Drivers
12.2 Celiac Drugs Market Restraints
12.3 Celiac Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Celiac Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Celiac Drugs
13.3 Celiac Drugs Production Process
13.4 Celiac Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Celiac Drugs Typical Distributors
14.3 Celiac Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Celiac Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Celiac Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 First Line Of Treatment
1.3.3 Second Line Of Treatment
1.4 Market Analysis by Application
1.4.1 Overview: Global Celiac Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Men
1.4.3 Women
1.4.4 Children
1.5 Global Celiac Drugs Market Size & Forecast
1.5.1 Global Celiac Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Celiac Drugs Sales Quantity (2019-2030)
1.5.3 Global Celiac Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 ADMA Biologics
2.1.1 ADMA Biologics Details
2.1.2 ADMA Biologics Major Business
2.1.3 ADMA Biologics Celiac Drugs Product and Services
2.1.4 ADMA Biologics Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 ADMA Biologics Recent Developments/Updates
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Celiac Drugs Product and Services
2.2.4 Amgen Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Amgen Recent Developments/Updates
2.3 Anthera Pharmaceuticals
2.3.1 Anthera Pharmaceuticals Details
2.3.2 Anthera Pharmaceuticals Major Business
2.3.3 Anthera Pharmaceuticals Celiac Drugs Product and Services
2.3.4 Anthera Pharmaceuticals Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Anthera Pharmaceuticals Recent Developments/Updates
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Celiac Drugs Product and Services
2.4.4 Bayer Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bayer Recent Developments/Updates
2.5 Biogen
2.5.1 Biogen Details
2.5.2 Biogen Major Business
2.5.3 Biogen Celiac Drugs Product and Services
2.5.4 Biogen Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Biogen Recent Developments/Updates
2.6 BioLineRx
2.6.1 BioLineRx Details
2.6.2 BioLineRx Major Business
2.6.3 BioLineRx Celiac Drugs Product and Services
2.6.4 BioLineRx Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 BioLineRx Recent Developments/Updates
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Celiac Drugs Product and Services
2.7.4 Biotest Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biotest Recent Developments/Updates
2.8 Bristol-Myers Squibb
2.8.1 Bristol-Myers Squibb Details
2.8.2 Bristol-Myers Squibb Major Business
2.8.3 Bristol-Myers Squibb Celiac Drugs Product and Services
2.8.4 Bristol-Myers Squibb Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Bristol-Myers Squibb Recent Developments/Updates
2.9 Celgene
2.9.1 Celgene Details
2.9.2 Celgene Major Business
2.9.3 Celgene Celiac Drugs Product and Services
2.9.4 Celgene Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Celgene Recent Developments/Updates
2.10 Celimmune
2.10.1 Celimmune Details
2.10.2 Celimmune Major Business
2.10.3 Celimmune Celiac Drugs Product and Services
2.10.4 Celimmune Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Celimmune Recent Developments/Updates
2.11 F Hoffmann-La Roche
2.11.1 F Hoffmann-La Roche Details
2.11.2 F Hoffmann-La Roche Major Business
2.11.3 F Hoffmann-La Roche Celiac Drugs Product and Services
2.11.4 F Hoffmann-La Roche Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 F Hoffmann-La Roche Recent Developments/Updates
2.12 ImmunogenX
2.12.1 ImmunogenX Details
2.12.2 ImmunogenX Major Business
2.12.3 ImmunogenX Celiac Drugs Product and Services
2.12.4 ImmunogenX Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 ImmunogenX Recent Developments/Updates
2.13 Immunomedics
2.13.1 Immunomedics Details
2.13.2 Immunomedics Major Business
2.13.3 Immunomedics Celiac Drugs Product and Services
2.13.4 Immunomedics Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Immunomedics Recent Developments/Updates
2.14 ImmusanT
2.14.1 ImmusanT Details
2.14.2 ImmusanT Major Business
2.14.3 ImmusanT Celiac Drugs Product and Services
2.14.4 ImmusanT Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 ImmusanT Recent Developments/Updates
2.15 Innovate Biopharmaceuticals
2.15.1 Innovate Biopharmaceuticals Details
2.15.2 Innovate Biopharmaceuticals Major Business
2.15.3 Innovate Biopharmaceuticals Celiac Drugs Product and Services
2.15.4 Innovate Biopharmaceuticals Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Innovate Biopharmaceuticals Recent Developments/Updates
2.16 Johnson & Johnson
2.16.1 Johnson & Johnson Details
2.16.2 Johnson & Johnson Major Business
2.16.3 Johnson & Johnson Celiac Drugs Product and Services
2.16.4 Johnson & Johnson Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Johnson & Johnson Recent Developments/Updates
2.17 Kedrion Biopharma
2.17.1 Kedrion Biopharma Details
2.17.2 Kedrion Biopharma Major Business
2.17.3 Kedrion Biopharma Celiac Drugs Product and Services
2.17.4 Kedrion Biopharma Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Kedrion Biopharma Recent Developments/Updates
2.18 LFB Group
2.18.1 LFB Group Details
2.18.2 LFB Group Major Business
2.18.3 LFB Group Celiac Drugs Product and Services
2.18.4 LFB Group Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 LFB Group Recent Developments/Updates
2.19 Merck
2.19.1 Merck Details
2.19.2 Merck Major Business
2.19.3 Merck Celiac Drugs Product and Services
2.19.4 Merck Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Merck Recent Developments/Updates
2.20 Novartis
2.20.1 Novartis Details
2.20.2 Novartis Major Business
2.20.3 Novartis Celiac Drugs Product and Services
2.20.4 Novartis Celiac Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Novartis Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CELIAC DRUGS BY MANUFACTURER
3.1 Global Celiac Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global Celiac Drugs Revenue by Manufacturer (2019-2024)
3.3 Global Celiac Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Celiac Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Celiac Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 Celiac Drugs Manufacturer Market Share in 2023
3.5 Celiac Drugs Market: Overall Company Footprint Analysis
3.5.1 Celiac Drugs Market: Region Footprint
3.5.2 Celiac Drugs Market: Company Product Type Footprint
3.5.3 Celiac Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Celiac Drugs Market Size by Region
4.1.1 Global Celiac Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global Celiac Drugs Consumption Value by Region (2019-2030)
4.1.3 Global Celiac Drugs Average Price by Region (2019-2030)
4.2 North America Celiac Drugs Consumption Value (2019-2030)
4.3 Europe Celiac Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific Celiac Drugs Consumption Value (2019-2030)
4.5 South America Celiac Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa Celiac Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Celiac Drugs Sales Quantity by Type (2019-2030)
5.2 Global Celiac Drugs Consumption Value by Type (2019-2030)
5.3 Global Celiac Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Celiac Drugs Sales Quantity by Application (2019-2030)
6.2 Global Celiac Drugs Consumption Value by Application (2019-2030)
6.3 Global Celiac Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Celiac Drugs Sales Quantity by Type (2019-2030)
7.2 North America Celiac Drugs Sales Quantity by Application (2019-2030)
7.3 North America Celiac Drugs Market Size by Country
7.3.1 North America Celiac Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America Celiac Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Celiac Drugs Sales Quantity by Type (2019-2030)
8.2 Europe Celiac Drugs Sales Quantity by Application (2019-2030)
8.3 Europe Celiac Drugs Market Size by Country
8.3.1 Europe Celiac Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe Celiac Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Celiac Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Celiac Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Celiac Drugs Market Size by Region
9.3.1 Asia-Pacific Celiac Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Celiac Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Celiac Drugs Sales Quantity by Type (2019-2030)
10.2 South America Celiac Drugs Sales Quantity by Application (2019-2030)
10.3 South America Celiac Drugs Market Size by Country
10.3.1 South America Celiac Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America Celiac Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Celiac Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Celiac Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Celiac Drugs Market Size by Country
11.3.1 Middle East & Africa Celiac Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Celiac Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Celiac Drugs Market Drivers
12.2 Celiac Drugs Market Restraints
12.3 Celiac Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Celiac Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Celiac Drugs
13.3 Celiac Drugs Production Process
13.4 Celiac Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Celiac Drugs Typical Distributors
14.3 Celiac Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Celiac Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Celiac Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. ADMA Biologics Basic Information, Manufacturing Base and Competitors
Table 4. ADMA Biologics Major Business
Table 5. ADMA Biologics Celiac Drugs Product and Services
Table 6. ADMA Biologics Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. ADMA Biologics Recent Developments/Updates
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Major Business
Table 10. Amgen Celiac Drugs Product and Services
Table 11. Amgen Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Amgen Recent Developments/Updates
Table 13. Anthera Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Anthera Pharmaceuticals Major Business
Table 15. Anthera Pharmaceuticals Celiac Drugs Product and Services
Table 16. Anthera Pharmaceuticals Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Anthera Pharmaceuticals Recent Developments/Updates
Table 18. Bayer Basic Information, Manufacturing Base and Competitors
Table 19. Bayer Major Business
Table 20. Bayer Celiac Drugs Product and Services
Table 21. Bayer Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Bayer Recent Developments/Updates
Table 23. Biogen Basic Information, Manufacturing Base and Competitors
Table 24. Biogen Major Business
Table 25. Biogen Celiac Drugs Product and Services
Table 26. Biogen Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Biogen Recent Developments/Updates
Table 28. BioLineRx Basic Information, Manufacturing Base and Competitors
Table 29. BioLineRx Major Business
Table 30. BioLineRx Celiac Drugs Product and Services
Table 31. BioLineRx Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. BioLineRx Recent Developments/Updates
Table 33. Biotest Basic Information, Manufacturing Base and Competitors
Table 34. Biotest Major Business
Table 35. Biotest Celiac Drugs Product and Services
Table 36. Biotest Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Biotest Recent Developments/Updates
Table 38. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 39. Bristol-Myers Squibb Major Business
Table 40. Bristol-Myers Squibb Celiac Drugs Product and Services
Table 41. Bristol-Myers Squibb Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Bristol-Myers Squibb Recent Developments/Updates
Table 43. Celgene Basic Information, Manufacturing Base and Competitors
Table 44. Celgene Major Business
Table 45. Celgene Celiac Drugs Product and Services
Table 46. Celgene Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Celgene Recent Developments/Updates
Table 48. Celimmune Basic Information, Manufacturing Base and Competitors
Table 49. Celimmune Major Business
Table 50. Celimmune Celiac Drugs Product and Services
Table 51. Celimmune Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Celimmune Recent Developments/Updates
Table 53. F Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 54. F Hoffmann-La Roche Major Business
Table 55. F Hoffmann-La Roche Celiac Drugs Product and Services
Table 56. F Hoffmann-La Roche Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. F Hoffmann-La Roche Recent Developments/Updates
Table 58. ImmunogenX Basic Information, Manufacturing Base and Competitors
Table 59. ImmunogenX Major Business
Table 60. ImmunogenX Celiac Drugs Product and Services
Table 61. ImmunogenX Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. ImmunogenX Recent Developments/Updates
Table 63. Immunomedics Basic Information, Manufacturing Base and Competitors
Table 64. Immunomedics Major Business
Table 65. Immunomedics Celiac Drugs Product and Services
Table 66. Immunomedics Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Immunomedics Recent Developments/Updates
Table 68. ImmusanT Basic Information, Manufacturing Base and Competitors
Table 69. ImmusanT Major Business
Table 70. ImmusanT Celiac Drugs Product and Services
Table 71. ImmusanT Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. ImmusanT Recent Developments/Updates
Table 73. Innovate Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Innovate Biopharmaceuticals Major Business
Table 75. Innovate Biopharmaceuticals Celiac Drugs Product and Services
Table 76. Innovate Biopharmaceuticals Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Innovate Biopharmaceuticals Recent Developments/Updates
Table 78. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 79. Johnson & Johnson Major Business
Table 80. Johnson & Johnson Celiac Drugs Product and Services
Table 81. Johnson & Johnson Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Johnson & Johnson Recent Developments/Updates
Table 83. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 84. Kedrion Biopharma Major Business
Table 85. Kedrion Biopharma Celiac Drugs Product and Services
Table 86. Kedrion Biopharma Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Kedrion Biopharma Recent Developments/Updates
Table 88. LFB Group Basic Information, Manufacturing Base and Competitors
Table 89. LFB Group Major Business
Table 90. LFB Group Celiac Drugs Product and Services
Table 91. LFB Group Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. LFB Group Recent Developments/Updates
Table 93. Merck Basic Information, Manufacturing Base and Competitors
Table 94. Merck Major Business
Table 95. Merck Celiac Drugs Product and Services
Table 96. Merck Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Merck Recent Developments/Updates
Table 98. Novartis Basic Information, Manufacturing Base and Competitors
Table 99. Novartis Major Business
Table 100. Novartis Celiac Drugs Product and Services
Table 101. Novartis Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Novartis Recent Developments/Updates
Table 103. Global Celiac Drugs Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 104. Global Celiac Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 105. Global Celiac Drugs Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 106. Market Position of Manufacturers in Celiac Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 107. Head Office and Celiac Drugs Production Site of Key Manufacturer
Table 108. Celiac Drugs Market: Company Product Type Footprint
Table 109. Celiac Drugs Market: Company Product Application Footprint
Table 110. Celiac Drugs New Market Entrants and Barriers to Market Entry
Table 111. Celiac Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Celiac Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 113. Global Celiac Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 114. Global Celiac Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 115. Global Celiac Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 116. Global Celiac Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 117. Global Celiac Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 118. Global Celiac Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 119. Global Celiac Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 120. Global Celiac Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 121. Global Celiac Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 122. Global Celiac Drugs Average Price by Type (2019-2024) & (USD/Unit)
Table 123. Global Celiac Drugs Average Price by Type (2025-2030) & (USD/Unit)
Table 124. Global Celiac Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 125. Global Celiac Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 126. Global Celiac Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 127. Global Celiac Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 128. Global Celiac Drugs Average Price by Application (2019-2024) & (USD/Unit)
Table 129. Global Celiac Drugs Average Price by Application (2025-2030) & (USD/Unit)
Table 130. North America Celiac Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 131. North America Celiac Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 132. North America Celiac Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 133. North America Celiac Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 134. North America Celiac Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 135. North America Celiac Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 136. North America Celiac Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 137. North America Celiac Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Europe Celiac Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 139. Europe Celiac Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 140. Europe Celiac Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 141. Europe Celiac Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 142. Europe Celiac Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 143. Europe Celiac Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 144. Europe Celiac Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 145. Europe Celiac Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 146. Asia-Pacific Celiac Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 147. Asia-Pacific Celiac Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 148. Asia-Pacific Celiac Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 149. Asia-Pacific Celiac Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 150. Asia-Pacific Celiac Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 151. Asia-Pacific Celiac Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 152. Asia-Pacific Celiac Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 153. Asia-Pacific Celiac Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 154. South America Celiac Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 155. South America Celiac Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 156. South America Celiac Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 157. South America Celiac Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 158. South America Celiac Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 159. South America Celiac Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 160. South America Celiac Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 161. South America Celiac Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 162. Middle East & Africa Celiac Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 163. Middle East & Africa Celiac Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 164. Middle East & Africa Celiac Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 165. Middle East & Africa Celiac Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 166. Middle East & Africa Celiac Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 167. Middle East & Africa Celiac Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 168. Middle East & Africa Celiac Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 169. Middle East & Africa Celiac Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 170. Celiac Drugs Raw Material
Table 171. Key Manufacturers of Celiac Drugs Raw Materials
Table 172. Celiac Drugs Typical Distributors
Table 173. Celiac Drugs Typical Customers
Table 1. Global Celiac Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Celiac Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. ADMA Biologics Basic Information, Manufacturing Base and Competitors
Table 4. ADMA Biologics Major Business
Table 5. ADMA Biologics Celiac Drugs Product and Services
Table 6. ADMA Biologics Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. ADMA Biologics Recent Developments/Updates
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Major Business
Table 10. Amgen Celiac Drugs Product and Services
Table 11. Amgen Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Amgen Recent Developments/Updates
Table 13. Anthera Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Anthera Pharmaceuticals Major Business
Table 15. Anthera Pharmaceuticals Celiac Drugs Product and Services
Table 16. Anthera Pharmaceuticals Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Anthera Pharmaceuticals Recent Developments/Updates
Table 18. Bayer Basic Information, Manufacturing Base and Competitors
Table 19. Bayer Major Business
Table 20. Bayer Celiac Drugs Product and Services
Table 21. Bayer Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Bayer Recent Developments/Updates
Table 23. Biogen Basic Information, Manufacturing Base and Competitors
Table 24. Biogen Major Business
Table 25. Biogen Celiac Drugs Product and Services
Table 26. Biogen Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Biogen Recent Developments/Updates
Table 28. BioLineRx Basic Information, Manufacturing Base and Competitors
Table 29. BioLineRx Major Business
Table 30. BioLineRx Celiac Drugs Product and Services
Table 31. BioLineRx Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. BioLineRx Recent Developments/Updates
Table 33. Biotest Basic Information, Manufacturing Base and Competitors
Table 34. Biotest Major Business
Table 35. Biotest Celiac Drugs Product and Services
Table 36. Biotest Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Biotest Recent Developments/Updates
Table 38. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 39. Bristol-Myers Squibb Major Business
Table 40. Bristol-Myers Squibb Celiac Drugs Product and Services
Table 41. Bristol-Myers Squibb Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Bristol-Myers Squibb Recent Developments/Updates
Table 43. Celgene Basic Information, Manufacturing Base and Competitors
Table 44. Celgene Major Business
Table 45. Celgene Celiac Drugs Product and Services
Table 46. Celgene Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Celgene Recent Developments/Updates
Table 48. Celimmune Basic Information, Manufacturing Base and Competitors
Table 49. Celimmune Major Business
Table 50. Celimmune Celiac Drugs Product and Services
Table 51. Celimmune Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Celimmune Recent Developments/Updates
Table 53. F Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 54. F Hoffmann-La Roche Major Business
Table 55. F Hoffmann-La Roche Celiac Drugs Product and Services
Table 56. F Hoffmann-La Roche Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. F Hoffmann-La Roche Recent Developments/Updates
Table 58. ImmunogenX Basic Information, Manufacturing Base and Competitors
Table 59. ImmunogenX Major Business
Table 60. ImmunogenX Celiac Drugs Product and Services
Table 61. ImmunogenX Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. ImmunogenX Recent Developments/Updates
Table 63. Immunomedics Basic Information, Manufacturing Base and Competitors
Table 64. Immunomedics Major Business
Table 65. Immunomedics Celiac Drugs Product and Services
Table 66. Immunomedics Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Immunomedics Recent Developments/Updates
Table 68. ImmusanT Basic Information, Manufacturing Base and Competitors
Table 69. ImmusanT Major Business
Table 70. ImmusanT Celiac Drugs Product and Services
Table 71. ImmusanT Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. ImmusanT Recent Developments/Updates
Table 73. Innovate Biopharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Innovate Biopharmaceuticals Major Business
Table 75. Innovate Biopharmaceuticals Celiac Drugs Product and Services
Table 76. Innovate Biopharmaceuticals Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Innovate Biopharmaceuticals Recent Developments/Updates
Table 78. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 79. Johnson & Johnson Major Business
Table 80. Johnson & Johnson Celiac Drugs Product and Services
Table 81. Johnson & Johnson Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Johnson & Johnson Recent Developments/Updates
Table 83. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors
Table 84. Kedrion Biopharma Major Business
Table 85. Kedrion Biopharma Celiac Drugs Product and Services
Table 86. Kedrion Biopharma Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Kedrion Biopharma Recent Developments/Updates
Table 88. LFB Group Basic Information, Manufacturing Base and Competitors
Table 89. LFB Group Major Business
Table 90. LFB Group Celiac Drugs Product and Services
Table 91. LFB Group Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. LFB Group Recent Developments/Updates
Table 93. Merck Basic Information, Manufacturing Base and Competitors
Table 94. Merck Major Business
Table 95. Merck Celiac Drugs Product and Services
Table 96. Merck Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Merck Recent Developments/Updates
Table 98. Novartis Basic Information, Manufacturing Base and Competitors
Table 99. Novartis Major Business
Table 100. Novartis Celiac Drugs Product and Services
Table 101. Novartis Celiac Drugs Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Novartis Recent Developments/Updates
Table 103. Global Celiac Drugs Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 104. Global Celiac Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 105. Global Celiac Drugs Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 106. Market Position of Manufacturers in Celiac Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 107. Head Office and Celiac Drugs Production Site of Key Manufacturer
Table 108. Celiac Drugs Market: Company Product Type Footprint
Table 109. Celiac Drugs Market: Company Product Application Footprint
Table 110. Celiac Drugs New Market Entrants and Barriers to Market Entry
Table 111. Celiac Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Celiac Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 113. Global Celiac Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 114. Global Celiac Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 115. Global Celiac Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 116. Global Celiac Drugs Average Price by Region (2019-2024) & (USD/Unit)
Table 117. Global Celiac Drugs Average Price by Region (2025-2030) & (USD/Unit)
Table 118. Global Celiac Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 119. Global Celiac Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 120. Global Celiac Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 121. Global Celiac Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 122. Global Celiac Drugs Average Price by Type (2019-2024) & (USD/Unit)
Table 123. Global Celiac Drugs Average Price by Type (2025-2030) & (USD/Unit)
Table 124. Global Celiac Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 125. Global Celiac Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 126. Global Celiac Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 127. Global Celiac Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 128. Global Celiac Drugs Average Price by Application (2019-2024) & (USD/Unit)
Table 129. Global Celiac Drugs Average Price by Application (2025-2030) & (USD/Unit)
Table 130. North America Celiac Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 131. North America Celiac Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 132. North America Celiac Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 133. North America Celiac Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 134. North America Celiac Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 135. North America Celiac Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 136. North America Celiac Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 137. North America Celiac Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Europe Celiac Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 139. Europe Celiac Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 140. Europe Celiac Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 141. Europe Celiac Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 142. Europe Celiac Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 143. Europe Celiac Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 144. Europe Celiac Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 145. Europe Celiac Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 146. Asia-Pacific Celiac Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 147. Asia-Pacific Celiac Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 148. Asia-Pacific Celiac Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 149. Asia-Pacific Celiac Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 150. Asia-Pacific Celiac Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 151. Asia-Pacific Celiac Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 152. Asia-Pacific Celiac Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 153. Asia-Pacific Celiac Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 154. South America Celiac Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 155. South America Celiac Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 156. South America Celiac Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 157. South America Celiac Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 158. South America Celiac Drugs Sales Quantity by Country (2019-2024) & (K Units)
Table 159. South America Celiac Drugs Sales Quantity by Country (2025-2030) & (K Units)
Table 160. South America Celiac Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 161. South America Celiac Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 162. Middle East & Africa Celiac Drugs Sales Quantity by Type (2019-2024) & (K Units)
Table 163. Middle East & Africa Celiac Drugs Sales Quantity by Type (2025-2030) & (K Units)
Table 164. Middle East & Africa Celiac Drugs Sales Quantity by Application (2019-2024) & (K Units)
Table 165. Middle East & Africa Celiac Drugs Sales Quantity by Application (2025-2030) & (K Units)
Table 166. Middle East & Africa Celiac Drugs Sales Quantity by Region (2019-2024) & (K Units)
Table 167. Middle East & Africa Celiac Drugs Sales Quantity by Region (2025-2030) & (K Units)
Table 168. Middle East & Africa Celiac Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 169. Middle East & Africa Celiac Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 170. Celiac Drugs Raw Material
Table 171. Key Manufacturers of Celiac Drugs Raw Materials
Table 172. Celiac Drugs Typical Distributors
Table 173. Celiac Drugs Typical Customers
LIST OF FIGURES
Figure 1. Celiac Drugs Picture
Figure 2. Global Celiac Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Celiac Drugs Consumption Value Market Share by Type in 2023
Figure 4. First Line Of Treatment Examples
Figure 5. Second Line Of Treatment Examples
Figure 6. Global Celiac Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Celiac Drugs Consumption Value Market Share by Application in 2023
Figure 8. Men Examples
Figure 9. Women Examples
Figure 10. Children Examples
Figure 11. Global Celiac Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Celiac Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Celiac Drugs Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Celiac Drugs Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Celiac Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Celiac Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Celiac Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Celiac Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Celiac Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Celiac Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Celiac Drugs Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Celiac Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Celiac Drugs Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Celiac Drugs Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Celiac Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Celiac Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Celiac Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Celiac Drugs Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Celiac Drugs Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Celiac Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Celiac Drugs Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Celiac Drugs Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Celiac Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Celiac Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Celiac Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Celiac Drugs Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Celiac Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Celiac Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Celiac Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Celiac Drugs Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Celiac Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Celiac Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Celiac Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Celiac Drugs Consumption Value Market Share by Region (2019-2030)
Figure 53. China Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Celiac Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Celiac Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Celiac Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Celiac Drugs Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Celiac Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Celiac Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Celiac Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Celiac Drugs Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Celiac Drugs Market Drivers
Figure 74. Celiac Drugs Market Restraints
Figure 75. Celiac Drugs Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Celiac Drugs in 2023
Figure 78. Manufacturing Process Analysis of Celiac Drugs
Figure 79. Celiac Drugs Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Celiac Drugs Picture
Figure 2. Global Celiac Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Celiac Drugs Consumption Value Market Share by Type in 2023
Figure 4. First Line Of Treatment Examples
Figure 5. Second Line Of Treatment Examples
Figure 6. Global Celiac Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Celiac Drugs Consumption Value Market Share by Application in 2023
Figure 8. Men Examples
Figure 9. Women Examples
Figure 10. Children Examples
Figure 11. Global Celiac Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Celiac Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Celiac Drugs Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Celiac Drugs Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Celiac Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Celiac Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Celiac Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Celiac Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Celiac Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Celiac Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Celiac Drugs Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Celiac Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Celiac Drugs Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Celiac Drugs Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Celiac Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Celiac Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Celiac Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Celiac Drugs Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Celiac Drugs Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Celiac Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Celiac Drugs Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Celiac Drugs Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Celiac Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Celiac Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Celiac Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Celiac Drugs Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Celiac Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Celiac Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Celiac Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Celiac Drugs Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Celiac Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Celiac Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Celiac Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Celiac Drugs Consumption Value Market Share by Region (2019-2030)
Figure 53. China Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Celiac Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Celiac Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Celiac Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Celiac Drugs Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Celiac Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Celiac Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Celiac Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Celiac Drugs Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Celiac Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Celiac Drugs Market Drivers
Figure 74. Celiac Drugs Market Restraints
Figure 75. Celiac Drugs Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Celiac Drugs in 2023
Figure 78. Manufacturing Process Analysis of Celiac Drugs
Figure 79. Celiac Drugs Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
